LL-37, Like all Cathelicidins, has antimicrobial, antibacterial, antiviral, anti-fungal and has been shown to reduce inflammation. Research has also shows that its effect against certain cancers and encourages blood vessel growth in specific settings.
Human Cathelicidin for Immune System Studies
LL-37 is the active form of human cathelicidin antimicrobial peptide (hCAP-18), playing crucial roles in innate immunity research and antimicrobial mechanism studies. This research peptide enables investigation of immune response pathways and host defense mechanisms.
Research Applications:
- Antimicrobial mechanism studies
- Innate immunity research
- Host defense pathway analysis
- Inflammation regulation studies
- Wound healing mechanism research
Product Features:
- 37-amino acid peptide
- Broad-spectrum activity
- High-purity preparation
- Suitable for immunity studies
For scientific research and development purposes only.
LL-37 5mg - Antimicrobial Peptide Research Compound
₹19,000.00Price
- Typical dosages can range, but commonly it’s 2mg per vial, which can be reconstituted with sterile water.
- The peptide is typically administered via subcutaneous injection.
- The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component).
- As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
- It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.
